Arnd Kaltofen-Ehmann

Arnd Kaltofen-Ehmann has held several positions in the corporate world since 2001. Arnd started as Managing Partner at VI Partners AG and then became a Board Director at Vara in 2022. In 2020, they were a Board Observer at HighLife, a Board Director at Araris Biotech AG, and an Investor at Oculis S.A. In 2017, they became a Board Director at Altoida. In 2016, they were a Board Director / Observer at Inositec AG and a Venture Partner at DiaMedCare. In 2012, they became a Board Director at Ventaleon GmbH and in 2009, they were a Board Director / Observer at JenaValve Technology, Inc.

Arnd Kaltofen-Ehmann completed their MD from the Universities of Ulm and Tübingen between 1980 and 1986. Arnd then pursued postgraduate studies in Computer Sciences at the Technical University of Munich from 1989 to 1991. From 1997 to 1999, they attended Northwestern University's Kellogg School of Management and WHU - Otto Beisheim School of Management, earning an MBA.